Langley Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$328K Buy
283
+27
+11% +$31.9K 0.32% 83
2026
Q2
$307K Buy
+256
New +$262K 0.3% 91

Other funds holding LLY

Langley Wealth Management's LLY Position: Q3 2026 in Review

Langley Wealth Management increased its Eli Lilly (LLY) stake by 11% in Q3 2026, buying an estimated $31.9K and bringing the position to 283 shares worth $328K. The position accounts for 0.32% of the portfolio, ranked #83.

Langley Wealth Management first reported a position in LLY in Q2 2026 and has held it in 2 quarters since. 4,630 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Langley Wealth Management held 283 shares of Eli Lilly worth $328K as of Q3 2026.
  • Langley Wealth Management bought 27 Eli Lilly shares in Q3 2026, an estimated $31.9K.
  • Eli Lilly made up 0.32% of Langley Wealth Management's portfolio in Q3 2026, its #83 holding.
  • Langley Wealth Management first reported a position in Eli Lilly in Q2 2026 and has held it in 2 quarters since.
  • 4,630 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Langley Wealth Management's 13F filing for Q3 2026, filed 4 Nov 2026.